查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827386

顯影劑市場按產品類型、影像方式、劑型、給藥途徑、應用和最終用戶分類－全球預測 2025-2032

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年顯影劑市場規模將成長至 123.5 億美元，複合年成長率為 8.20%。

主要市場統計數據
基準年2024年 65.7億美元
預計2025年 70.8億美元
預測年份：2032年 123.5億美元
複合年成長率（%） 8.20%

權威介紹，闡述了不斷變化的臨床需求、監管重點和供應鏈動態為何正在重新定義全球顯影劑決策

顯影劑是現代診斷影像的基石，使各專業的臨床醫生能夠在製定治療決策時，以高保真度可視化解剖學和生理學特徵。診斷影像硬體、軟體和顯影劑化學的最新進展擴展了臨床應用，同時也提高了監管機構的關注度和供應鏈審查力度。在此背景下，醫院、診斷中心和門診手術中心等相關人員擴大尋求能夠平衡療效和安全性、並針對患者併發症進行客製化的造影劑。因此，製造商、採購團隊和臨床負責人正在重新評估處方優先事項、籌資策略以及與設備和軟體合作夥伴的合作模式。

此外，人們對個人化醫療和價值導向照護的期望日益成長，這正在改變顯影劑的評估方式。付款人和醫療系統不再孤立地評估顯影劑，而是尋求將顯影劑的選擇與診斷結果、後續護理途徑和患者預後聯繫起來的證據。同時，新的劑型和給藥途徑為給藥和工作流程帶來了實際考慮，影響了造影劑的採用。鑑於這些趨勢，深入了解顯影劑使用的臨床和營運因素對於產品開發、市場拓展以及與臨床指南的一致性至關重要。本介紹將為詳細探討結構性變化、關稅影響、細分洞察、區域動態和策略建議奠定基礎。

技術創新、監管力度加強以及更具彈性的供應鏈如何重新調整顯影劑臨床和商業相關人員的優先事項

顯影劑造影劑市場格局正在經歷變革時期，這得益於技術進步、監管格局的調整以及消費者預期的共同作用，這些因素正在重塑臨床和市場行為。影像技術的創新，包括更高解析度的 CT 和 MRI 序列以及更先進的超音波平台，正在推動對造影更高、安全性更高的造影劑的需求。同時，製造商正在投資配方科學，以提高穩定性、降低不利事件發生率，並最佳化與下一代成像通訊協定的兼容性。

同時，隨著監管機構加強上市後監管並完善藥品安全指南，企業正在加強藥物安全檢測能力，並投資於真實世界證據的生成。全球疫情的衝擊已將供應鏈韌性提升為策略重點，鼓勵企業實現製造地多元化，並與製造外包更緊密地合作，以確保連續性。以病人為中心的醫療模式和付款人監督正在產生壓力，要求企業透過與結果相關的證據和精簡的醫院工作流程來證明臨床價值。這些趨勢正在推動一個更一體化的生態系統，在這個生態系統中，製造商、臨床醫生、付款人和採購負責人必須在安全性、有效性和營運效率方面保持一致，以維持應用和創新。

評估新的關稅現實如何促使策略採購調整、對本地製造的投資以及採購重新設計以保護臨床供應的連續性

近期實施的關稅和貿易政策調整為顯影劑的全球籌資策略帶來了新的複雜性，並對製造、分銷和臨床供應鏈產生了連鎖反應。關稅帶來的成本壓力促使供應商和經銷商重新評估採購區域，評估本地生產的可行性，並與醫療保健提供者重新協商合約條款。因此，採購團隊越來越關注總擁有成本 (TCO)，而不僅僅是單位成本，同時還要考慮物流、庫存持有成本以及與替代採購安排相關的潛在合規費用。

為此，一些製造商正在加快對區域製造能力和夥伴關係關係的投資，以實現更靈活的供應安排。這些調整旨在降低跨境營運相關的營運風險，並維持對臨床站點的持續存取。同時，醫療系統和診斷中心正在探索戰略採購模式，例如框架協議和長期供應契約，以提供產量和價格的可預測性。透過這些調整，相關人員正在平衡對不間斷臨床供應的需求與不斷變化的貿易政策帶來的財務現實，在維護醫療服務的連續性的同時保護其組織的利潤。

深度細分主導的洞察，將產品屬性、臨床模式、給藥途徑、應用和最終用戶動態與策略決策聯繫起來

粒度細分鏡頭揭示了顯影劑領域的差異化動態，可為產品策略、臨床採用和商業化策略提供資訊。依產品類型，市場分為鋇基顯影劑、钆基顯影劑、碘基顯影劑和微氣泡顯影劑，每個類別提供不同的物理化學特性、安全性和臨床適應症。以顯像模式，分析了電腦斷層掃描 (CT)、磁振造影(MRI)、光學成像、超音波和 X 光/螢光透視法，反映了特定於方式對造影增強、時間解析度和藥物相容性的要求。根據形式，實際劑量和儲存考慮區分液體、糊狀和粉末製劑，影響庫存管理和照護現場準備程序。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 與鎖狀化合物相比，大環钆藥物的安全性更高，因此對大環钆藥物的需求正在增加
  • 實施人工智慧驅動的演算法，根據患者生理特徵和掃描方式調整顯影劑劑劑量
  • 為了減少副作用，放射中心對低滲透碘顯影劑的使用急劇增加。
  • 監管部門強調钆沉積的安全性，促使某些藥物改變配方並撤出市場
  • 利用奈米粒子造影示蹤劑進行標造影影像在腫瘤診斷與治療監測的應用
  • 可攜式CEUS 在急診和嚴重監護中的應用日益廣泛，推動了對超音波套件的需求。
  • 為了解決成像程序對環境的影響，該行業正在轉向永續的顯影劑處理和回收解決方案。

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章顯影劑市場（依產品類型）

  • 鋇基顯影劑
  • 钆基顯影劑
  • 碘化顯影劑
  • 微氣泡顯影劑

第9章顯影劑市場（依影像方式）

  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 光學成像
  • 超音波
  • X光和螢光透視

第10章 對比顯影劑市場（依形式）

  • 液體
  • 貼上
  • 粉末

第 11 章。按管理途徑分類的顯影劑市場

  • 血管內途徑
  • 口服途徑
  • 直腸途徑

第12章顯影劑市場（依應用）

  • 癌症
  • 心血管疾病
  • 胃腸道疾病
  • 肌肉骨骼疾病
  • 腎臟疾病
  • 神經系統疾病

第 13 章。顯影劑市場（按最終用戶分類）

  • 門診手術中心
  • 診斷影像中心
  • 醫院

第14章顯影劑市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章顯影劑市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章。各國顯影劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Acro Lifesciences（I）Pvt. Ltd.
    • APOLLO RT Co. Ltd.
    • Bayer AG
    • Beijing Beilu Pharmaceutical Co., Ltd.
    • Bracco Spa
    • Covis Group
    • Daiichi Sankyo Co. Ltd.
    • Fuji Pharma Co. Ltd.
    • GE Healthcare
    • Guerbet SA
    • iMAX Diagnostic Imaging Limited
    • JB Chemicals & Pharmaceuticals Limited
    • Jodas Expoim Pvt. Ltd.
    • Lantheus Medical Imaging, Inc.
    • M.Biotech Limited
    • MEDTRON AG
    • nanoPET Pharma GmbH
    • SANOCHEMIA Pharmazeutika GmbH
    • Spago Nanomedical AB
    • Trivitron Healthcare
    • ulrich GmbH & Co. KG
    • Vitalquan, LLC
Product Code: MRR-434CCDA04E9E

The Contrast Media Market is projected to grow by USD 12.35 billion at a CAGR of 8.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.57 billion
Estimated Year [2025] USD 7.08 billion
Forecast Year [2032] USD 12.35 billion
CAGR (%) 8.20%

An authoritative introduction framing why evolving clinical needs, regulatory priorities, and supply chain dynamics are redefining contrast media decision-making worldwide

Contrast media remain a cornerstone of modern diagnostic imaging, enabling clinicians to visualize anatomy and physiology with fidelity that guides treatment decisions across a wide range of specialties. Recent advances in imaging hardware, software, and contrast agent chemistry have converged to expand clinical applications while intensifying regulatory attention and supply chain scrutiny. In this context, stakeholders across hospitals, diagnostic centers, and ambulatory surgical facilities increasingly demand agents that balance efficacy with safety profiles tailored to patient comorbidities. Consequently, manufacturers, procurement teams, and clinical leaders are reassessing formulary priorities, procurement strategies, and collaboration models with device and software partners.

Moreover, evolving expectations around personalized medicine and value-based care are shifting how contrast media are evaluated. Payers and health systems seek evidence that links contrast selection to diagnostic yield, downstream care pathways, and patient outcomes rather than evaluating agents in isolation. At the same time, novel delivery forms and routes introduce practical considerations for administration and workflow that influence adoption. In light of these developments, a nuanced understanding of the clinical and operational factors shaping contrast media utilization is essential for product development, market access, and clinical guideline alignment. This introduction sets the stage for deeper examination of structural shifts, tariff impacts, segmentation insights, regional dynamics, and strategic recommendations that follow.

How technological innovation, reinforced regulatory scrutiny, and supply chain resilience are collectively reshaping priorities across clinical and commercial stakeholders in contrast media

The contrast media landscape is undergoing transformative shifts driven by technological advances, regulatory recalibration, and consumer expectations that together are reshaping clinical practice and market behavior. Innovations in imaging modalities, including higher-resolution CT and MRI sequences and more sophisticated ultrasound platforms, have increased demand for agents that offer greater contrast differentiation while maintaining enhanced safety profiles. Concurrently, manufacturers are investing in formulation science to improve stability, reduce adverse event rates, and optimize compatibility with next-generation imaging protocols.

At the same time, regulators are intensifying post-market surveillance and refining guidance on agent safety, which has prompted companies to enhance pharmacovigilance capabilities and invest in real-world evidence generation. Supply chain resilience has emerged as a strategic priority following global disruptions, prompting diversification of manufacturing footprints and closer collaboration with contract manufacturers to safeguard continuity. Patient-centered care models and payer scrutiny are creating pressure to demonstrate clinical value through outcome-linked evidence and streamlined hospital workflows. Together, these trends are driving a more integrated ecosystem in which manufacturers, clinicians, payers, and procurement leaders must align on safety, effectiveness, and operational efficiency to sustain adoption and innovation.

Assessing how new tariff realities are prompting strategic sourcing adjustments, regional production investments, and procurement redesigns to protect clinical supply continuity

Recent tariff implementations and trade policy adjustments have introduced new layers of complexity into global procurement strategies for contrast media, with implications that reverberate through manufacturing, distribution, and clinical supply chains. Tariff-driven cost pressures have prompted suppliers and distributors to reassess sourcing geographies, evaluate the feasibility of localized production, and renegotiate contractual terms with healthcare providers. As a result, procurement teams are increasingly focusing on total cost of ownership rather than unit price alone, taking into account logistics, inventory carrying costs, and potential regulatory compliance expenditures associated with alternative sourcing arrangements.

In response, some manufacturers are accelerating investments in regional manufacturing capacity and in partnerships that enable more flexible supply arrangements. These adjustments aim to mitigate the operational risks associated with cross-border duties and to preserve stable access for clinical settings. Meanwhile, health systems and diagnostic centers are exploring strategic procurement models such as framework agreements and longer-term supply contracts that provide predictability in volumes and pricing. Through these adaptive measures, stakeholders seek to balance the need for uninterrupted clinical supply with the financial realities imposed by shifting trade policies, thereby maintaining continuity of care while protecting organizational margins.

Deep segmentation-driven insights that align product attributes, clinical modalities, administration routes, applications, and end-user dynamics to strategic decision-making

A granular segmentation lens reveals differentiated dynamics that inform product strategy, clinical adoption, and commercialization tactics across the contrast media domain. Based on Product Type, the market is examined through the lens of Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media, each category carrying distinct physicochemical properties, safety considerations, and clinical indications. Based on Imaging Modality, adoption patterns are analyzed across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy, reflecting modality-specific requirements for contrast enhancement, temporal resolution, and agent compatibility. Based on Form, practical administration and storage considerations differentiate Liquid, Paste, and Powder formulations, which influence inventory management and point-of-care preparation routines.

Based on Route of Administration, clinical workflows and patient preparation vary markedly across Intravascular Route, Oral Route, and Rectal Route applications, shaping both safety protocols and nursing time allocation. Based on Application, therapeutic and diagnostic priorities across Cancer, Cardiovascular Diseases, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders dictate distinct performance benchmarks and evidence expectations. Based on End User, the procurement environment and utilization patterns differ across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals, each with unique budget cycles, clinical throughput, and regulatory oversight. Integrating these segmentation axes enables tailored market approaches that align product attributes with clinical needs, operational realities, and reimbursement considerations.

Regional dynamics and strategic approaches tailored to diverse regulatory regimes, healthcare infrastructures, and adoption patterns across major global regions

Regional variation in demand drivers, regulatory frameworks, and healthcare infrastructure produces distinct strategic imperatives across the world's major markets. In the Americas, market dynamics are shaped by consolidated hospital systems, widespread adoption of advanced imaging technologies, and payer models that emphasize clinical outcomes and cost-effectiveness; these conditions favor agents with robust safety data and clear operational advantages. Europe, Middle East & Africa present a heterogeneous regulatory environment where divergent national reimbursement approaches and variable infrastructure maturity create opportunities for differentiated market entry strategies, regional manufacturing partnerships, and targeted clinical evidence generation. In Asia-Pacific, rapid diagnostic capacity expansion, substantial investments in imaging infrastructure, and large patient populations are encouraging faster adoption cycles for new formulations and modality-specific agents, although procurement practices often vary by national policy and hospital tier.

Consequently, manufacturers and distributors must develop regionally nuanced strategies that account for local regulatory timelines, reimbursement landscapes, and distribution networks. Strategic collaborations with regional clinical opinion leaders and targeted real-world evidence programs can accelerate acceptance in markets with high clinical demand while addressing specific safety and logistical considerations. By aligning commercial models with regional healthcare system characteristics and clinician workflows, stakeholders can optimize access and ensure consistent supply across diverse operating environments.

Strategic company imperatives emphasizing rigorous manufacturing, evidence generation, and partnership-driven commercialization to secure clinical and procurement preference

Competitive positioning within the contrast media landscape depends on a combination of scientific differentiation, manufacturing reliability, regulatory compliance, and commercial partnerships. Leading organizations focus on portfolio depth and formulation innovation to meet modality-specific and application-specific needs, while emerging players concentrate on niche segments where novel chemistries or delivery forms can offer clear clinical advantages. Quality systems and GMP-compliant manufacturing are central to building trust with large hospital systems and diagnostic networks, and companies that demonstrate consistent supply reliability earn preferred supplier status in many procurement environments.

Furthermore, strategic alliances with imaging device manufacturers, clinical research networks, and distribution partners amplify reach and support evidence generation initiatives. Firms that invest in post-market surveillance and real-world outcomes studies strengthen their clinical narratives and facilitate smoother regulatory interactions. In addition, cost management through process efficiencies, contract manufacturing relationships, and inventory optimization enables competitive pricing without compromising margins. Together, these capabilities determine which companies can sustainably meet the evolving expectations of clinicians, procurement teams, and regulators while positioning themselves for long-term growth in increasingly sophisticated imaging markets.

Clear operational and clinical actions for leaders to strengthen product differentiation, supply resilience, and evidence-driven commercial strategies in contrast media

Industry leaders should pursue a set of actionable priorities that balance clinical innovation, supply resilience, and evidence-based commercialization to navigate near-term disruption and prepare for long-term adoption trends. First, invest in formulation and safety science to improve agent tolerability and to differentiate products for modality-specific use cases; this includes pursuing clinical studies and real-world evidence programs that tie contrast selection to diagnostic accuracy and patient outcomes. Second, prioritize supply chain diversification and regional manufacturing partnerships to reduce exposure to trade policy volatility and to ensure predictable availability across high-volume clinical settings. Third, align commercial strategies with end-user workflows by offering administration-ready formats and by supporting training initiatives that reduce time-to-adoption in busy imaging centers.

Additionally, develop payer engagement plans that articulate value in terms meaningful to decision-makers, such as reduced downstream procedures or improved diagnostic confidence. Strengthen partnerships with imaging hardware and software vendors to co-develop integrated solutions that optimize contrast utilization and image analytics. Finally, embed robust pharmacovigilance and post-market surveillance capabilities to sustain regulatory compliance and to build clinician trust. Taken together, these steps will help organizations achieve competitive advantage while safeguarding patient safety and operational continuity.

A transparent, reproducible research methodology combining primary stakeholder interviews and rigorous secondary evidence synthesis to validate clinical and commercial insights

This research synthesizes primary and secondary sources through a structured, reproducible methodology designed to capture clinical, regulatory, and commercial perspectives across the contrast media landscape. Primary inputs include stakeholder interviews with clinical end users, procurement specialists, and regulatory professionals to capture frontline experiences and to validate operational hypotheses. Secondary inputs draw on peer-reviewed clinical literature, regulatory advisories, manufacturing guidance, and publicly available institutional reports to build a comprehensive evidence base for safety profiles, modality requirements, and administrative practices. Data integrity is ensured through cross-validation of qualitative inputs against published clinical studies and regulatory documentation.

Analytical steps include segmentation mapping to align product attributes with clinical and operational use cases, scenario analysis to explore the implications of trade policy shifts and supply disruptions, and synthesis of regional regulatory considerations to inform market access strategies. Throughout the process, findings were reviewed by domain experts to ensure clinical relevance and to correct for potential bias. The methodology emphasizes transparency, reproducibility, and a pragmatic focus on decision-relevant insights that can inform procurement, clinical adoption, and product development strategies.

A concise conclusion emphasizing how innovation, evidence, and supply resilience will determine clinical adoption and commercial success in contrast media

In conclusion, the contrast media sector sits at an inflection point where scientific innovation, regulatory evolution, and logistical resilience converge to define competitive advantage. Advancements in imaging technology and formulation science are opening new clinical pathways, while payers and health systems demand stronger links between diagnostic choices and patient outcomes. Trade policy and supply chain volatility have reinforced the need for diversified manufacturing strategies and predictable distribution networks. Consequently, successful organizations will be those that couple demonstrable safety and efficacy with supply reliability and clear value narratives that resonate with clinicians and procurement leaders alike.

Looking ahead, the most impactful opportunities will arise from aligning product development with modality-specific demands, investing in real-world evidence that supports clinical and economic value, and forging partnerships that integrate contrast agents with imaging hardware and analytics platforms. By adopting these approaches, stakeholders can both safeguard clinical supply continuity and unlock new avenues for improved diagnostic care. The synthesis provided here is intended to support strategic choices that enhance patient safety, operational efficiency, and long-term commercial viability across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing demand for macrocyclic gadolinium agents due to enhanced safety profile over linear compounds
  • 5.2. Implementation of AI-driven algorithms to tailor contrast dosing based on patient physiology and scan modality
  • 5.3. Surge in low-osmolality iodinated contrast utilization in radiology centers aiming for reduced adverse reactions
  • 5.4. Regulatory emphasis on gadolinium deposition safety prompting reformulation and market withdrawal of certain agents
  • 5.5. Adoption of nanoparticle-based contrast tracers for targeted molecular imaging in oncology diagnostics and treatment monitoring
  • 5.6. Expansion of portable CEUS applications in emergency and critical care driving demand for ultrasound contrast media kits
  • 5.7. Industry shift towards sustainable contrast disposal and recycling solutions to address environmental impact of imaging procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Contrast Media Market, by Product Type

  • 8.1. Barium-based Contrast Media
  • 8.2. Gadolinium-based Contrast Media
  • 8.3. Iodinated Contrast Media
  • 8.4. Microbubble Contrast Media

9. Contrast Media Market, by Imaging Modality

  • 9.1. Computed Tomography (CT)
  • 9.2. Magnetic Resonance Imaging (MRI)
  • 9.3. Optical Imaging
  • 9.4. Ultrasound
  • 9.5. X-Ray & Fluoroscopy

10. Contrast Media Market, by Form

  • 10.1. Liquid
  • 10.2. Paste
  • 10.3. Powder

11. Contrast Media Market, by Route of Administration

  • 11.1. Intravascular Route
  • 11.2. Oral Route
  • 11.3. Rectal Route

12. Contrast Media Market, by Application

  • 12.1. Cancer
  • 12.2. Cardiovascular Diseases
  • 12.3. Gastrointestinal Disorders
  • 12.4. Musculoskeletal Disorders
  • 12.5. Nephrological Disorders
  • 12.6. Neurological Disorders

13. Contrast Media Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals

14. Contrast Media Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Contrast Media Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Contrast Media Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Acro Lifesciences (I) Pvt. Ltd.
    • 17.3.2. APOLLO RT Co. Ltd.
    • 17.3.3. Bayer AG
    • 17.3.4. Beijing Beilu Pharmaceutical Co., Ltd.
    • 17.3.5. Bracco Spa
    • 17.3.6. Covis Group
    • 17.3.7. Daiichi Sankyo Co. Ltd.
    • 17.3.8. Fuji Pharma Co. Ltd.
    • 17.3.9. GE Healthcare
    • 17.3.10. Guerbet SA
    • 17.3.11. iMAX Diagnostic Imaging Limited
    • 17.3.12. J. B. Chemicals & Pharmaceuticals Limited
    • 17.3.13. Jodas Expoim Pvt. Ltd.
    • 17.3.14. Lantheus Medical Imaging, Inc.
    • 17.3.15. M.Biotech Limited
    • 17.3.16. MEDTRON AG
    • 17.3.17. nanoPET Pharma GmbH
    • 17.3.18. SANOCHEMIA Pharmazeutika GmbH
    • 17.3.19. Spago Nanomedical AB
    • 17.3.20. Trivitron Healthcare
    • 17.3.21. ulrich GmbH & Co. KG
    • 17.3.22. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 296. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 297. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 298. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 299. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 300. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 301. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 338. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 339. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 340. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 341. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 342. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 343. G7 CONTRAST MEDIA MARK